Characteristics of all AML patients with CR versus no CR
Characteristic . | CR . | No CR . | P . |
|---|---|---|---|
| No. patients | 1046 | 791 | |
| Female sex, no. (%) | 468 (59) | 323 (41) | NS |
| Median age, y (range) | 55 (15-89) | 64 (16-89) | <.001 |
| Performance status 3/4, no. (%) | 63 (30) | 150 (70) | NS |
| AHD/MDS, no. (%) | 317 (44) | 406 (56) | .012 |
| Median platelet count, × 109/L (range) | 52 (1-1 355) | 45 (3-2 292) | <.001 |
| Median WBC count, × 109/L (range) | 10.2 (0.4-390) | 11.7 (0.2-437) | NS |
| Median Hgb level, g/dL (range) | 8.2 (2.1-14.9) | 7.9 (2.8-15) | .003 |
| Median PT, s (range) | 12.3 (10.2-29.9) | 12.8 (9.9-49.7) | <.001 |
| Median PTT, s (range) | 27.8 (14.6-277) | 28 (11.8-294) | .062 |
| Median β2-M level, mg/dL (range) | 2.6 (<0.1-30.6) | 3.3 (0.7-31.3) | <.001 |
| Median total bilirubin level, mg/dL (range) | 0.6 (0.1-7.4) | 0.6 (0.1-9.2) | <.001 |
| Median BM blast, % (range) | 55 (0-98) | 50.5 (0-98) | .003 |
| Median LDH level, IU/L (range) | 1 030.5 (190-33 349) | 1 177 (125-58 856) | .003 |
| Cytogenetics, no. (%) | |||
| Poor | 250 (41) | 360 (59) | <.001 |
| Other | 661 (61) | 418 (39) | – |
| Favorable | 135 (91) | 13 (9) | – |
| M7 AML, no. (%) | 16 (43) | 21 (57) | .089 |
| Laminar flow room treatment, no. (%) | 625 (60) | 421 (540) | NS |
Characteristic . | CR . | No CR . | P . |
|---|---|---|---|
| No. patients | 1046 | 791 | |
| Female sex, no. (%) | 468 (59) | 323 (41) | NS |
| Median age, y (range) | 55 (15-89) | 64 (16-89) | <.001 |
| Performance status 3/4, no. (%) | 63 (30) | 150 (70) | NS |
| AHD/MDS, no. (%) | 317 (44) | 406 (56) | .012 |
| Median platelet count, × 109/L (range) | 52 (1-1 355) | 45 (3-2 292) | <.001 |
| Median WBC count, × 109/L (range) | 10.2 (0.4-390) | 11.7 (0.2-437) | NS |
| Median Hgb level, g/dL (range) | 8.2 (2.1-14.9) | 7.9 (2.8-15) | .003 |
| Median PT, s (range) | 12.3 (10.2-29.9) | 12.8 (9.9-49.7) | <.001 |
| Median PTT, s (range) | 27.8 (14.6-277) | 28 (11.8-294) | .062 |
| Median β2-M level, mg/dL (range) | 2.6 (<0.1-30.6) | 3.3 (0.7-31.3) | <.001 |
| Median total bilirubin level, mg/dL (range) | 0.6 (0.1-7.4) | 0.6 (0.1-9.2) | <.001 |
| Median BM blast, % (range) | 55 (0-98) | 50.5 (0-98) | .003 |
| Median LDH level, IU/L (range) | 1 030.5 (190-33 349) | 1 177 (125-58 856) | .003 |
| Cytogenetics, no. (%) | |||
| Poor | 250 (41) | 360 (59) | <.001 |
| Other | 661 (61) | 418 (39) | – |
| Favorable | 135 (91) | 13 (9) | – |
| M7 AML, no. (%) | 16 (43) | 21 (57) | .089 |
| Laminar flow room treatment, no. (%) | 625 (60) | 421 (540) | NS |